Combination therapy versus monotherapy with moderately severe to severe Alzheimer’s disease

Zanfina Ademi; Heiner C. Bucher; Dominik Glinz; Viktoria  Gloy; Samia Hurst; Kimberly Alba McCord; Heike  Raatz; Urs Saxer; Matthias Schwenkglenks; Joris Van Stiphout; Yuki Tomonaga

Combination therapy versus monotherapy with moderately severe to severe Alzheimer’s disease

Zanfina Ademi
, Heiner C. Bucher
, Dominik Glinz
, Viktoria Gloy
, Samia Hurst
, Kimberly Alba McCord
, Heike Raatz
, Urs Saxer
, Matthias Schwenkglenks
, Joris Van Stiphout
, Yuki Tomonaga

Research output: Book/Report › Commissioned Report › Research › peer-review

Original language	English
Place of Publication	Zürich Switzerland
Publisher	Swiss Medical Board
Commissioning body	Schweizer medizinisches Board (Swiss Medical Board)
Number of pages	164
Publication status	Published - 2017
Externally published	Yes

Access to Document

312723274-oaFinal published version, 1.95 MB

https://www.swissmedicalboard.ch/fileadmin/public/news/2017/assessment_report_smb_antidementia_long_2017.pdf

Cite this

Ademi, Z., Bucher, H. C., Glinz, D., Gloy , V., Hurst, S., Alba McCord, K., Raatz, H., Saxer, U., Schwenkglenks, M., Van Stiphout, J., & Tomonaga, Y. (2017). Combination therapy versus monotherapy with moderately severe to severe Alzheimer’s disease. Swiss Medical Board. https://www.swissmedicalboard.ch/fileadmin/public/news/2017/assessment_report_smb_antidementia_long_2017.pdf

@book{e94cdeeb29984bcd8c73f19470c498a5,

title = "Combination therapy versus monotherapy with moderately severe to severe Alzheimer{\textquoteright}s disease",

author = "Zanfina Ademi and Bucher, \{Heiner C.\} and Dominik Glinz and Viktoria Gloy and Samia Hurst and \{Alba McCord\}, Kimberly and Heike Raatz and Urs Saxer and Matthias Schwenkglenks and \{Van Stiphout\}, Joris and Yuki Tomonaga",

year = "2017",

language = "English",

publisher = "Swiss Medical Board",

}

Ademi, Z, Bucher, HC, Glinz, D, Gloy , V, Hurst, S, Alba McCord, K, Raatz, H, Saxer, U, Schwenkglenks, M, Van Stiphout, J & Tomonaga, Y 2017, Combination therapy versus monotherapy with moderately severe to severe Alzheimer’s disease. Swiss Medical Board, Zürich Switzerland. <https://www.swissmedicalboard.ch/fileadmin/public/news/2017/assessment_report_smb_antidementia_long_2017.pdf>

TY - BOOK

T1 - Combination therapy versus monotherapy with moderately severe to severe Alzheimer’s disease

AU - Ademi, Zanfina

AU - Bucher, Heiner C.

AU - Glinz, Dominik

AU - Gloy , Viktoria

AU - Hurst, Samia

AU - Alba McCord, Kimberly

AU - Raatz, Heike

AU - Saxer, Urs

AU - Schwenkglenks, Matthias

AU - Van Stiphout, Joris

AU - Tomonaga, Yuki

PY - 2017

Y1 - 2017

M3 - Commissioned Report

BT - Combination therapy versus monotherapy with moderately severe to severe Alzheimer’s disease

PB - Swiss Medical Board

CY - Zürich Switzerland

ER -